HCPCS Code Detail Logo

HCPCS Codes Similar to G0307

HCPCS Codes Similar to “G0307” Code.
Complete (cbc), automated (hgb, hct, rbc, wbc; without platelet count)

G0306
Complete cbc, automated (hgb, hct, rbc, wbc, without platelet count) and automated wbc differential count
Code added date: 20040101
Code effective date: 20090101
ED
Hematocrit level has exceeded 39% (or hemoglobin level has exceeded 13.0 g/dl) for 3 or more consecutive billing cycles immediately prior to and including the current cycle
Code added date: 20080101
Code effective date: 20080101
EE
Hematocrit level has not exceeded 39% (or hemoglobin level has not exceeded 13.0 g/dl) for 3 or more consecutive billing cycles immediately prior to and including the current cycle
Code added date: 20080101
Code effective date: 20080101
G9638
Final reports without documentation of one or more dose reduction techniques (e.g., automated exposure control, adjustment of the ma and/or kv according to patient size, use of iterative reconstruction technique)
Code added date: 20160101
Code effective date: 20160101
C8921
Transthoracic echocardiography with contrast, or without contrast followed by with contrast, for congenital cardiac anomalies; complete
Code added date: 20080101
Code effective date: 20080101
C8923
Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, without spectral or color doppler echocardiography
Code added date: 20080101
Code effective date: 20090101
C8929
Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography
Code added date: 20090101
Code effective date: 20090101
A9569
Technetium tc-99m exametazime labeled autologous white blood cells, diagnostic, per study dose
Code added date: 20080101
Code effective date: 20250101
A9570
Indium in-111 labeled autologous white blood cells, diagnostic, per study dose
Code added date: 20080101
Code effective date: 20250101
G0681
Application of a premarket approval (pma), 510(k), 361 human cells, tissues or cellular and tissue-based products (hct/p) non-sheet form skin substitute for a wound surface area up to 100 sq cm; first 25 sq cm or less of wound surface area
Code added date: 20260401
Code effective date: 20260401
G0682
Application of a premarket approval (pma), 510(k), 361 human cells, tissues or cellular and tissue-based products (hct/p) non-sheet form skin substitute for a wound surface area up to 100 sq cm; each additional 25 sq cm wound surface area, or part thereof (list separately in addition to code for primary procedure)
Code added date: 20260401
Code effective date: 20260401
G0683
Application of a premarket approval (pma), 510(k), 361 human cells, tissues or cellular and tissue-based products (hct/p) non-sheet form skin substitute graft for a wound surface greater than or equal to 100 sq cm; first 100 sq cm wound surface area, or 1% of body area of infants and children
Code added date: 20260401
Code effective date: 20260401
G0684
Application of a premarket approval (pma), 510(k), 361 human cells, tissues or cellular and tissue-based products (hct/p) non-sheet form skin substitute graft for a wound surface greater than or equal to 100 sq cm; each additional 100 sq cm wound surface area or part thereof, or each additional 1% of body area of infants and children, or part thereof (list separately in addition to code for primary procedure)
Code added date: 20260401
Code effective date: 20260401
Q4433
361 hct/p skin substitute product, not otherwise specified (list in addition to primary procedure)
Code added date: 20260101
Code effective date: 20260101